Brief: Aytu Biopharma Subleases A Portion Of Its Manufacturing Facility
May 1 (Reuters) - Aytu Biopharma Inc AYTU.O :
* AYTU BIOPHARMA SUBLEASES A PORTION OF ITS MANUFACTURING
FACILITY
* AYTU BIOPHARMA INC - SUBLEASE REPRESENTS OVER 30% OF CO’S
FDA
AND DEA-APPROVED PHARMACEUTICAL MANUFACTURING FACILITY.
* AYTU- COMMENCING AS EARLY AS APRIL 1, 2024, BUT NO LATER
THAN
DECEMBER 31, 2024, SUBLEASE WILL BE EXPANDED TO INCLUDE REST OF
MANUFACTURING FACILITY
Source: [ID: https://bit.ly/3nlytxN]
Further company coverage: AYTU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aytu Biopharma
See all newsAytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales
Aytu Biopharma Inc expected to post a loss of 32 cents a share - Earnings Preview
Aytu BioPharma Q3 revenue falls amid EXXUA launch
Aytu BioPharma Q2 revenue beats expectations